bluuebunny/crossref_metadata_2025_split huggingface dataset:
Development of a predictive nomogram for intermediate-risk differentiated thyroid cancer patients after fixed 3.7GBq (100mCi) radioiodine remnant ablation
Authors: Lu Lu , Li Qiang , Ge Zhao , Lu Yanqi , Lin Chunhao , Lv Jinfu , Huang Jinquan , Mu Xingyu , Fu Wei 
Published: May 2024

ObjectivesThe objective of this study was to develop a predictive nomogram for intermediate-risk differentiated thyroid cancer (DTC) patients after fixed 3.7GBq (100mCi) radioiodine remnant ablation (RRA).MethodsData from 265 patients who underwent total thyroidectomy with central lymph node dissection (CND) and received RRA treatment at a single institution between January 2018 and March 2023 were analyzed. Patients with certain exclusion criteria were excluded. Univariate and multivariate logistic regression analyses were performed to identify risk factors for a non-excellent response (non-ER) to RRA. A nomogram was developed based on the risk factors, and its performance was validated using the Bootstrap method with 1,000 resamplings. A web-based dynamic calculator was developed for convenient application of the nomogram.ResultsThe study included 265 patients with intermediate-risk DTC. Significant differences were found between the ER group and the non-ER group in terms of CLNM&gt;5, Hashimoto’s thyroiditis, sTg level, TgAb level (P &lt; 0.05). CLNM&gt;5 and sTg level were identified as independent risk factors for non-ER in multivariate analysis. The nomogram showed high accuracy, with an area under the curve (AUC) of 0.833 (95% CI = 0.770–0.895). The nomogram’s predicted probabilities aligned closely with actual clinical outcomes.ConclusionsThis study developed a predictive nomogram for intermediate-risk DTC patients after fixed 3.7GBq (100mCi) RRA. The nomogram incorporates CLNM&gt;5 and sTg levels as risk factors for a non-ER response to RRA. The nomogram and web-based calculator can assist in treatment decision-making and improve the precision of prognosis information. Further research and validation are needed.
Clinical characteristics and long-term management for patients with vitamin D-dependent rickets type II: a retrospective study at a single center in Saudi Arabia
Authors: Alsagheir Afaf , Al-Ashwal Abdullah , Binladen Amal , Alhuthil Raghad , Joueidi Faisal , Ramzan Khushnooda , Imtiaz Faiqa 
Published: May 2024

IntroductionHereditary Vitamin D-dependent rickets type II (HVDDR-type II) is a rare autosomal recessive disorder caused by molecular variation in the gene encoding the vitamin D receptor (VDR). This study aims to evaluate phenotype and genotype characteristics and long-term follow-up of the largest group of patients with (HVDDR-type II) in Saudi Arabia.MethodologyWe conducted a retrospective chart review to collect the clinical, biochemical, and genetic data for all HVDDR-type II patients currently receiving treatment at King Faisal Specialist Hospital &amp; Research Centre, Riyadh, Saudi Arabia.ResultsA total of 42 patients, 57.1% female, and 42.9% male were included in the study. Seven patients were treated with high doses of oral calcium, while 35 patients were treated with IV calcium infusion. The median age at presentation was 15.5 months. Alopecia was found in 97.6%, 21.4% presented with bowing legs, 14.3% with delayed walking, 9.5% with seizure, and 2.4% presented with respiratory failure, while a family history of the disease was positive in 71.4% of total patients. Molecular genetic testing of the VDR gene in our cohort identified six different gene variants c.885 C&gt;A (p.Tyr295Ter), c.88 C&gt;T (p.Arg30Ter), c.1036G&gt;A (p.Val346Met), c.820C&gt;T (p.Arg274Cys), c.803 T&gt;C (p.Ile268Thr), and c.2T&gt;G (p.Met1?).ConclusionWe are describing the largest cohort of patients with HVDDR-type II, their clinical biochemical findings, and the most prevalent genetic variants in our population.
Distribution of volatile organic compounds (VOCs) in the urban atmosphere of Hangzhou, East China: Temporal variation, source attribution, and impact on the secondary formations of ozone and aerosol
Authors: Wang Xin , Han Yu , Tu Xiang , Shen Jiandong , Zhang Baojun , Fu Hongbo 
Published: May 2024

Volatile organic compounds (VOCs) significantly influence air quality, atmospheric chemistry, and human health. An observational study was performed at the urban site of Hangzhou, China, to analyze VOC characteristics, sources, chemical reactivities, and their impact on ozone (O3) and secondary organic aerosol (SOA) formation throughout the year 2021. During the observation period, alkanes (40.13%) emerging as the predominant VOC species. Seasonal variation in VOCs followed the order of winter (26.49 ppb) &gt; spring (23.63 ppb) &gt; summer (23.62 ppb) &gt; autumn (20.47 ppb). The results of positive matrix factorization (PMF) revealed that solvent usage, combustion, and vehicle exhaust were the dominant VOC sources. Regional transport from nearby provinces also significantly contributed to VOC levels. These contributions varied seasonally, with southeastern air masses prevailing in both spring and autumn, eastern air masses impacting summer, and northwestern air masses affecting winter. The campaign-averaged value of total hydroxyl (OH) radicals was 19.08 s−1. NO2 accounted for the most significant contribution to the overall OH reactivity (39.11%), followed by VOCs (28.72%). Notable seasonal fluctuations in OH reactivity followed the order of winter (24.20 s−1) &gt; spring (19.22 s−1) &gt; autumn (18.07 s−1) &gt; summer (14.86 s−1). The average ozone formation potential (OFP) for the measured VOCs was calculated as 75.54 ppb, with alkenes being the dominant contributor. The highest value was observed in spring (83.05 ppb), the lowest value was in autumn (60.43 ppb). The SOA formation potential, mainly contributed by the aromatics, was averaged as 2.92 μg m−3. Additionally, the top four SOA-contributing species across four seasons were toluene, benzene, m-xylene, and ethylbenzene. VOC–PM2.5 sensitivity analysis showed that VOCs exhibited higher sensitivity to PM2.5 on clean level (PM2.5 &lt; 35 μg m−3) than on level with heavy pollution. Alkenes, oxygenated volatile organic compounds (OVOCs) and aromatics played significant roles in the transformations of O3 and SOA in Hangzhou. Therefore, controlling the concentrations of these species is crucial for reducing complex atmospheric pollution in the region. Overall, this study compiles scientific evidence on pollution sources in Hangzhou, providing the government with valuable information.
Prediction of miRNAs and diseases association based on sparse autoencoder and MLP
Authors: Sun Si-Lin , Zhou Bing-Wei , Liu Sheng-Zheng , Xiu Yu-Han , Bilal Anas , Long Hai-Xia 
Published: May 2024

Introduction: MicroRNAs (miRNAs) are small and non-coding RNA molecules which have multiple important regulatory roles within cells. With the deepening research on miRNAs, more and more researches show that the abnormal expression of miRNAs is closely related to various diseases. The relationship between miRNAs and diseases is crucial for discovering the pathogenesis of diseases and exploring new treatment methods.Methods: Therefore, we propose a new sparse autoencoder and MLP method (SPALP) to predict the association between miRNAs and diseases. In this study, we adopt advanced deep learning technologies, including sparse autoencoder and multi-layer perceptron (MLP), to improve the accuracy of predicting miRNA-disease associations. Firstly, the SPALP model uses a sparse autoencoder to perform feature learning and extract the initial features of miRNAs and diseases separately, obtaining the latent features of miRNAs and diseases. Then, the latent features combine miRNAs functional similarity data with diseases semantic similarity data to construct comprehensive miRNAs-diseases datasets. Subsequently, the MLP model can predict the unknown association among miRNAs and diseases.Result: To verify the performance of our model, we set up several comparative experiments. The experimental results show that, compared with traditional methods and other deep learning prediction methods, our method has significantly improved the accuracy of predicting miRNAs-disease associations, with 94.61% accuracy and 0.9859 AUC value. Finally, we conducted case study of SPALP model. We predicted the top 30 miRNAs that might be related to Lupus Erythematosus, Ecute Myeloid Leukemia, Cardiovascular, Stroke, Diabetes Mellitus five elderly diseases and validated that 27, 29, 29, 30, and 30 of the top 30 are indeed associated.Discussion: The SPALP approach introduced in this study is adept at forecasting the links between miRNAs and diseases, addressing the complexities of analyzing extensive bioinformatics datasets and enriching the comprehension contribution to disease progression of miRNAs.
Newcastle disease virus vector-based SARS-CoV-2 vaccine candidate AVX/COVID-12 activates T cells and is recognized by antibodies from COVID-19 patients and vaccinated individuals
Authors: Torres-Flores Alejandro , Ontiveros-Padilla Luis Alberto , Madera-Sandoval Ruth Lizzeth , Tepale-Segura Araceli , Gajón-Martínez Julián , Rivera-Hernández Tania , Ferat-Osorio Eduardo Antonio , Cérbulo-Vázquez Arturo , Arriaga-Pizano Lourdes Andrea , Bonifaz Laura , Paz-De la Rosa Georgina , Rojas-Martínez Oscar , Suárez-Martínez Alejandro , Peralta-Sánchez Gustavo , Sarfati-Mizrahi David , Sun Weina , Chagoya-Cortés Héctor Elías , Palese Peter , Krammer Florian , García-Sastre Adolfo , Lozano-Dubernard Bernardo , López-Macías Constantino 
Published: May 2024

IntroductionSeveral effective vaccines for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been developed and implemented in the population. However, the current production capacity falls short of meeting global demand. Therefore, it is crucial to further develop novel vaccine platforms that can bridge the distribution gap. AVX/COVID-12 is a vector-based vaccine that utilizes the Newcastle Disease virus (NDV) to present the SARS-CoV-2 spike protein to the immune system.MethodsThis study aims to analyze the antigenicity of the vaccine candidate by examining antibody binding and T-cell activation in individuals infected with SARS-CoV-2 or variants of concern (VOCs), as well as in healthy volunteers who received coronavirus disease 2019 (COVID-19) vaccinations.ResultsOur findings indicate that the vaccine effectively binds antibodies and activates T-cells in individuals who received 2 or 3 doses of BNT162b2 or AZ/ChAdOx-1-S vaccines. Furthermore, the stimulation of T-cells from patients and vaccine recipients with AVX/COVID-12 resulted in their proliferation and secretion of interferon-gamma (IFN-γ) in both CD4+ and CD8+ T-cells.DiscussionThe AVX/COVID-12 vectored vaccine candidate demonstrates the ability to stimulate robust cellular responses and is recognized by antibodies primed by the spike protein present in SARS-CoV-2 viruses that infected patients, as well as in the mRNA BNT162b2 and AZ/ChAdOx-1-S vaccines. These results support the inclusion of the AVX/COVID-12 vaccine as a booster in vaccination programs aimed at addressing COVID-19 caused by SARS-CoV-2 and its VOCs.
Quality of evidence supporting the role of probiotics for rheumatoid arthritis: an overview of systematic reviews
Authors: Li Weiqing , Zhang Yalan , Guo Dandan , Gong Rui , Yuan Jiaxin , Yang Huijun 
Published: May 2024

BackgroundTo evaluate the methodological quality, report quality, and evidence quality of meta-analysis (MA) and systematic review (SR) on the efficacy of probiotics in the treatment of rheumatoid arthritis (RA).MethodsDatabases were used to identify eligible SRs/MAs until February 12, 2024. The methodological quality of the studies was assessed using AMSTAR-2 tool, the quality of the literature reports was scored using PRISMA checklists, and the quality of the evidence was graded using GRADE system.ResultsSeven reviews including 21 outcomes were included. Methodological quality of the included reviews was of general low, and the entries with poor scores were 2, 4, and 7. By PRISMA checklists, there were some reporting deficiencies, and quality problems were mainly reflected in the reporting registration and protocol, comprehensive search strategy and additional analysis. GRADE results elevated the quality of evidence to be low or very low overall.ConclusionsProbiotics may have a therapeutic effect on RA, based on the evidence provided by the SRs/MAs in this overview. Nevertheless, there is still a lack of conclusive evidence due to methodological limitations in the included research. To make trustworthy judgments regarding the efficacy of probiotics in the treatment of RA, more large-scale, high-quality randomized controlled trials are still required.
The causal effect of adipose tissue on Hodgkin’s lymphoma: two-sample Mendelian randomization study and validation
Authors: Wu Lihua , Liao Fei , Guo Xiangli , Li Nainong 
Published: May 2024

BackgroundExtensive research has been conducted on the correlation between adipose tissue and the risk of malignant lymphoma. Despite numerous observational studies exploring this connection, uncertainty remains regarding a causal relationship between adipose tissue and malignant lymphoma.MethodsThe increase or decrease in adipose tissue was represented by the height of BMI. The BMI and malignant lymphoma genome-wide association studies (GWAS) used a summary dataset from the OPEN GWAS website. Single-nucleotide polymorphisms (SNPs) that met the criteria of P &lt;5e–8 and LD of r2 = 0.001 in the BMI GWAS were chosen as genetic instrumental variants (IVs). Proxy SNPs with LD of r2 &gt; 0.8 were identified, while palindromic and outlier SNPs were excluded. Mendelian randomization (MR) analysis used five methods, including inverse-variance weighted (IVW) model, weighted median (WM), MR-Egger, simple mode, and weighted mode. Sensitivity assessments included Cochran’s Q test, MR-Egger intercept test, and leave-one-out analysis. Participants randomly selected by the National Center for Health Statistics (NHANSE) and newly diagnosed HL patients at Fujian Medical University Union Hospital were used for external validation.ResultsThe results of the MR analysis strongly supported the causal link between BMI and Hodgkin’s lymphoma (HL). The research demonstrated that individuals with lower BMI face a significantly increased risk of developing HL, with a 91.65% higher risk (ORIVW = 0.0835, 95% CI 0.0147 – 0.4733, P = 0.005). No signs of horizontal or directional pleiotropy were observed in the MR studies. The validation results aligned with the results from the MR analysis (OR = 0.871, 95% CI 0.826 – 0.918, P&lt; 0.001). And there was no causal relationship between BMI and non-Hodgkin’s lymphoma (NHL).ConclusionsThe MR analysis study demonstrated a direct correlation between lower BMI and HL. This suggested that a decrease in adipose tissue increases the risk of developing HL. Nevertheless, further research is essential to grasp the underlying mechanism of this causal association comprehensively.
Integrated mRNA–miRNA transcriptome profiling of blood immune responses potentially related to pulmonary fibrosis in forest musk deer
Authors: Qi Wen-Hua , Hu Li-Fan , Gu Yu-Jiawei , Zhang Xiao-Yan , Jiang Xue-Mei , Li Wu-Jiao , Qi Jun-Sheng , Xiao Guo-Sheng , Jie Hang 
Published: May 2024

BackgroundForest musk deer (FMD, Moschus Berezovskii) is a critically endangered species world-widely, the death of which can be caused by pulmonary disease in the farm. Pulmonary fibrosis (PF) was a huge threat to the health and survival of captive FMD. MicroRNAs (miRNAs) and messenger RNAs (mRNAs) have been involved in the regulation of immune genes and disease development. However, the regulatory profiles of mRNAs and miRNAs involved in immune regulation of FMD are unclear.MethodsIn this study, mRNA-seq and miRNA-seq in blood were performed to constructed coexpression regulatory networks between PF and healthy groups of FMD. The hub immune- and apoptosis-related genes in the PF blood of FMD were explored through Gene Ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis. Further, protein–protein interaction (PPI) network of immune-associated and apoptosis-associated key signaling pathways were constructed based on mRNA-miRNA in the PF blood of the FMD. Immune hub DEGs and immune hub DEmiRNAs were selected for experimental verification using RT-qPCR.ResultsA total of 2744 differentially expressed genes (DEGs) and 356 differentially expressed miRNAs (DEmiRNAs) were identified in the PF blood group compared to the healthy blood group. Among them, 42 DEmiRNAs were negatively correlated with 20 immune DEGs from a total of 57 correlations. The DEGs were significantly associated with pathways related to CD molecules, immune disease, immune system, cytokine receptors, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, cytokine-cytokine receptor interaction, intestinal immune network for IgA production, and NOD-like receptor signaling pathway. There were 240 immune-related DEGs, in which 186 immune-related DEGs were up-regulated and 54 immune-related DEGs were down-regulated. In the protein-protein interaction (PPI) analysis of immune-related signaling pathway, TYK2, TLR2, TLR4, IL18, CSF1, CXCL13, LCK, ITGB2, PIK3CB, HCK, CD40, CD86, CCL3, CCR7, IL2RA, TLR3, and IL4R were identified as the hub immune genes. The mRNA-miRNA coregulation analysis showed that let-7d, miR-324-3p, miR-760, miR-185, miR-149, miR-149-5p, and miR-1842-5p are key miRNAs that target DEGs involved in immune disease, immune system and immunoregulation.ConclusionThe development and occurrence of PF were significantly influenced by the immune-related and apoptosis-related genes present in PF blood. mRNAs and miRNAs associated with the development and occurrence of PF in the FMD.
Current situation and issues regarding termination of risk management plans in Japan
Authors: Kameyama Natsuko , Hosaka Aoi , Maeda Hideki 
Published: May 2024

IntroductionIn Japan, drugs approved after the 2013 implementation of the risk management plan (RMP) have the opportunity to be evaluated for RMP termination. However, the guidelines for risk management following the termination of an RMP remain unclear. Drugs are evaluated for RMP termination at the timing of reexamination. Reexamination system is unique to Japan and initiated in 1979, verifies the approved efficacy and safety of a newly marketed drug based on the data from its actual use over a certain period. This study investigated drugs in Japan for which the RMP requirement was lifted upon reexamination and those for which it was not. We organized their characteristics and considered future issues.MethodsWe identified drugs with RMPs and obtained information on RMP termination from the public website of the Pharmaceuticals and Medical Devices Agency (PMDA). The survey period spanned 10 years, from April 2013, when the RMP was implemented, to March 2023.ResultsDuring the survey period, 72 drugs with RMPs completed reexamination in Japan. The RMP requirement was lifted for 69 drugs (95.8%) and remained for three drugs (4.2%). Upon RMP termination, 16 out of 69 drugs (23.2%) had important potential risks not listed in the package insert, with malignant neoplasm being the most common. Eleven drugs (15.9%) had important missing information not listed in the package insert, with the most common being the impact on cardiovascular risk. Two drugs (2.9%) had ongoing additional pharmacovigilance activities, and 43 drugs (62.3%) had additional risk minimization activities.ConclusionUpon reexamination completion, the RMP requirement was lifted for many drugs and remained for a few. Should safety concerns require continued attention following reexamination, we advocate for the continuation of the RMP, guided by more explicit rules. In light of the harmonization of RMP rules with those of other countries, there is a desire for enhanced drug safety management.
Prognostic value of the systemic immune-inflammation index in critically ill elderly patients with hip fracture: evidence from MIMIC (2008–2019)
Authors: Liu Zhen-Jiang , Li Gen-He , Wang Jing-Xuan , Mo Zhi-Hong , Yang Kang-Yong , Shen Chu-Long , Shen Zhao-Xiong 
Published: May 2024

BackgroundThe systemic immune-inflammation index (SII) showed an extensive link between immunological dysfunction and the activation of systemic inflammation. Several studies have confirmed the application of SII to orthopedic diseases. However, the significance of SII in critically ill elderly individuals with hip fracture who require intensive care unit (ICU) admission is not yet known. This study centered on exploring the relationship between SII and clinical outcomes among critically ill elderly hip fracture individuals.MethodsThe study centered around elderly patients experiencing severe illness following hip fractures and requiring admission to the ICU. These patients from the MIMIC-IV database formed the basis of this study’s cohort. We stratified them into quartiles according to their SII levels. The results involved the mortality at 30 days and 1 year post-admission. Then we employ Cox proportional hazards regression analysis as well as restricted cubic splines to explore the association between the SII and clinical results in critically ill elderly patients with hip fracture.ResultsThe study encompassed 991 participants, among whom 63.98% identified as females. Notably, the mortality rates attributed to any cause within 30 days and 1 year after hospitalization stood at 19.68 and 33.40%, respectively. The multivariate Cox proportional hazards model disclosed a significant correlation between an elevated SII and all-cause mortality. Following adjustments for confounding variables, individuals with a high SII showed a notable correlation with 30-day mortality [adjusted hazard ratio (HR), 1.065; 95% confidence interval (CI), 1.044–1.087; p &lt; 0.001] and 1-year mortality (adjusted HR, 1.051; 95% CI, 1.029–1.074; p &lt; 0.001). Furthermore, the analysis of restricted cubic splines demonstrated a progressive increase in the risk of all-cause death as the SII value rose.ConclusionAmong critically ill elderly patients with hip fracture, the SII exhibits a non-linear association that positively correlates with both 30-day and 1-year all-cause mortality rates. The revelation indicates that the SII may play a vital role in identifying patients with hip fractures who face an escalated risk of mortality due to any cause.